Trial intelligence / Profile preview

Intrathecal Bupivacaine-Dexmedetomidine Compared to Intrathecal Bupivacaine-Neostigmine in Elective Caesarean Sections

NCT06055101Completed

Start
Jan 2019
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine and neostigmine in Obstetric anesthesia (3 arms). Primary endpoint: Time started from the end of intrathecal injection till achievement of a bilateral sensory block at T10. Started Jan 2019; status: completed.

02

Drugs

dexmedetomidineneostigmine
03

Conditions

Obstetric anesthesia

Beyond the preview

Go deeper on NCT06055101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06055101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call